#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Septic arthritis in light of the guidelines of the French Society for Rheumatology


Authors: M. Klein
Authors‘ workplace: Revmatologický ústav Praha
Published in: Čes. Revmatol., 31, 2023, No. 3, p. 137-144.
Category: Reviews

Overview

Septic arthritis is an infectious inflammation of the joint, often accompanied by general symptoms. It is a serious, often life-threatening disease that often has significant functional consequences. Pre-existing joint involvement, polymorbidity, and immunosuppressive treatment represent significant risk factors relevant to the rheumatology patient population, for the occurrence, difficulty of diagnosis, and treatment. Despite these facts, there are still no national or international guidelines for the management of septic arthritis in rheumatology. This work presents the new recommendations of the French Society for Rheumatology, which thus provides important guidance in the management of septic arthritis. In three basic principles, they emphasize urgent and focused diagnosis, unambiguous identification of the causative agent, including sensitivity to antimicrobial therapy, and an interdisciplinary approach for maximum patient benefit; the following 16 recommendations are individually devoted to assessment of severity, differential diagnosis, diagnosis, including laboratory, the role of imaging methods, therapy, options for interventional treatment and rehabilitation.

Keywords:

guidelines – septic arthritis


Sources
  1. Cooper C, Cawley MI. Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis 1986; 45(6): 458–463.
  2. García-De La Torre I. Advances in the management of septic arthritis. Infect Dis Clin North Am 2006; 20(4): 773–788.
  3. Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985; 312(12): 764–771.
  4. Ross JJ, et al. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis 2003; 36(3): 319–327.
  5. Sharp JT, et al. Infectious arthritis. Arch Intern Med 1979; 139(10): 1125–1130.
  6. Farley MM. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 2001; 33(4): 556–561.
  7. Belkhir L, et al. Pneumococcal septic arthritis in adults: clinical analysis and review. Acta Clin Belg 2014; 69(1): 40–46.
  8. Pulido M, Sorvillo F. Declining invasive pneumococcal disease mortality in the United States 1990–2005. Vaccine 2010; 28(4): 889–892.
  9. Adams WG, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269(2): 221–226.
  10. Goldenberg DL, et al. Acute arthritis caused by gram-negative bacilli: a clinical characterization. Medicine (Baltimore) 1974; 53(3): 197–208.
  11. Bayer AS, et al. Gram-negative bacillary septic arthritis: clinical, radiographic, therapeutic, and prognostic features. Semin Arthritis Rheum 1977; 7(2): 123–132.
  12. Newman ED, Davis DE, Harrington TM. Septic arthritis due to gram negative bacilli: older patients with good outcome. J Rheumatol 1988; 15(4): 659–662.
  13. O’Brien JP, Goldenberg DL, Rice A. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983; 62(6): 395–406.
  14. Weston VC, et al. Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis 1999; 58(4): 214–219.
  15. Edwards SA, Cranfield T, Clarke HJ. Atypical presentation of septic arthritis in the immunosuppressed patient. Orthopedics 2002; 25(10): 1089–1090.
  16. Kaandorp CJ, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 1997; 56(8): 470–475.
  17. Dubost JJ, et al. Polyarticular septic arthritis. Medicine (Baltimore) 1993; 72(5): 296–310.
  18. García-Arias M, Balsa A, Mola EM. Septic arthritis. Best Pract Res Clin Rheumatol 2011; 25(3): 407–421.
  19. Horowitz DL, et al. Approach to septic arthritis. Am Fam Physician 2011; 84(6): 653–660.
 
  1. Morgan DS, et al. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 1996; 117(3): 423–428.
  2. Kaandorp CJ, et al. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum 1995; 38(12): 1819–1825.
  3. Edwards CJ, et al. The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57(7): 1151–1157.
  4. Kim HW, et al. Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy 2023; 62(8): 2740–2747.
  5. Galloway JB, et al. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011; 70(10): 1810–1814.
  6. Fraenkel L, Bathon JM, England BR. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis 2021; 73(7): 924–939.
  7. 3rd anti-infectious therapy consensus conference osteoarticular bacterial infections apart from mycobacterial infections 25th January 1991 – Tours. Médecine et Maladies Infectieuses 1991; 21(8–9): 440–449.
  8. Couderc, M, et al. 2020 French recommendations on the management of septic arthritis in an adult native joint. Joint Bone Spine 2020; 87(6): 538–547.
  9. Abram SGF, et al. Mortality and adverse joint outcomes following septic arthritis of the native knee: a longitudinal cohort study of patients receiving arthroscopic washout. Lancet Infect Dis 2020; 20(3): 341–349.
  10. Carpenter CR, et al. Evidence-based diagnostics: adult septic arthritis. Acad Emerg Med 2011; 18(8): 781–796.
  11. Broy SB, Schmid FR. A comparison of medical drainage (needle aspiration) and surgical drainage (arthrotomy or arthroscopy) in the initial treatment of infected joints. Clin Rheum Dis 1986; 12(2): 501–522.
  12. Couderc M, et al. Predictive value of the usual clinical signs and laboratory tests in the diagnosis of septic arthritis. CJEM 2015; 17(4): 403–410.
  13. Ferrand J, et al. Morbimortality in adult patients with septic arthritis: a three-year hospital-based study. BMC Infect Dis 2016; 16: 239.
  14. Nolla JM, et al. Pyogenic arthritis of native joints in non-intravenous drug users: A detailed analysis of 268 cases attended in a tertiary hospital over a 22-year period. Semin Arthritis Rheum 2015; 45(1): 94–102.
  15. Lieber SB, et al. Clinical characteristics and outcomes in polyarticular septic arthritis. Joint Bone Spine 2018; 85(4): 469–473.
  16. Maneiro JR, et al. Predictors of treatment failure and mortality in native septic arthritis. Clin Rheumatol 2015; 34(11): 1961–1967.
  17. Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8): 801– 810.
  18. Hughes JG, et al. Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol 2001; 39(12): 4468–4471.
  19. Coiffier G, et al. Broad-range 16 s rDNA PCR in synovial fluid does not improve the diagnostic performance of septic arthritis in native joints in adults: cross-sectional single-center study in 95 patients 2019; 38(7): 1985–1992.
  20. Ferreyra M, et al. Combining cytology and microcrystal detection in nonpurulent joint fluid benefits the diagnosis of septic arthritis. Joint Bone Spine 2017; 84(1): 65–70.
  21. Shah K, et al. Does the presence of crystal arthritis rule out septic arthritis? J Emerg Med 2007; 32(1): 23–26.
  1. Coakley G, et al. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology (Oxford) 2006; 45(8): 1039–1041.
  2. Habib G, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36(44): 3075–3128.
  3. Moussiegt A, et al. Gonococcal arthritis: case series of 58 hospital cases. Clin Rheumatol 2022; 41(9): 2855–2862.
  4. McBride S, et al. Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults. Clin Infect Dis 2020; 70(2): 271–279.
  5. Shaikh MM, Hermans LE, van Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist’s repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology (Oxford) 2015; 54(2): 231–240.
  6. Zhao J, et al. Serum procalcitonin levels as a diagnostic marker for septic arthritis: A meta-analysis. Am J Emerg Med 2017; 35(8): 1166–1171.
  7. Karchevsky M, et al. MRI findings of septic arthritis and associated osteomyelitis in adults. AJR Am J Roentgenol 2004; 182(1): 119–122.
  8. Bierry G, et al. MRI findings of treated bacterial septic arthritis. Skeletal Radiol 2012; 41(12): 1509–1516.
  9. Palestro CJ. FDG-PET in musculoskeletal infections. Semin Nucl Med 2013; 43(5): 367–376.
  10. Filippucci E, et al. Ultrasound in crystal-related arthritis. Clin Exp Rheumatol 2014; 32(1 Suppl 80): S42–47.
  11. Beaman FD, et al. ACR Appropriateness Criteria(®) Suspected Osteomyelitis, Septic Arthritis, or Soft Tissue Infection (Excluding Spine and Diabetic Foot). J Am Coll Radiol 2017; 14(5s): S326– s337.
  12. González-Juanatey C, et al. Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study. Medicine (Baltimore) 2001; 80(1): 9–19.
  13. Stengel D, et al. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001; 1(3): 175–188.
  14. Norden C, et al. Evaluation of new anti-infective drugs for the treatment of infectious arthritis in adults. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15(Suppl 1): S167–171.

  1. Mathews CJ, et al. Bacterial septic arthritis in adults. Lancet 2010; 375(9717): 846–855.
  2. Bardin T, Gonococcal arthritis. Best Pract Res Clin Rheumatol 2003; 17(2): 201–208.
  3. Musil D, et al. (Native Joint Septic Arthritis in Adults: Incidence in Our Group of Patients and Antibiotic Therapy Guidelines). Acta Chir Orthop Traumatol Cech 2021; 88(5): 354–361.
  4. Riegels-Nielson P, Frimodt-Möller N, Jensen JS. Rabbit model of septic arthritis. Acta Orthop Scand 1987; 58(1): 14–19.
  5. Kodumuri P, Geutjens G, Kerr HL. Time delay between diagnosis and arthroscopic lavage in septic arthritis. Does it matter? Int Orthop 2012; 36(8): 1727–1731.
  6. Lauper N, et al. Native septic arthritis is not an immediate surgical emergency. J Infect 2018; 77(1): 47–53.
  7. Ravindran V, Logan I, Bourke BE. Medical vs surgical treatment for the native joint in septic arthritis: a 6-year, single UK academic centre experience. Rheumatology (Oxford) 2009; 48(10): 1320–1322.
  8. Harada K, et al. Native Joint Septic Arthritis: Comparison of Outcomes with Medical and Surgical Management. South Med J 2019; 112(4): 238–243.
  9. Flores-Robles BJ, et al. Medical Versus Surgical Approach to Initial Treatment in Septic Arthritis: A Single Spanish Center’s 8-Year Experience. J Clin Rheumatol 2019; 25(1): 4–8.
  10. Johns BP, Loewenthal MR, Dewar DC. Open Compared with Arthroscopic Treatment of Acute Septic Arthritis of the Native Knee. J Bone Joint Surg Am 2017; 99(6): 499–505.
  11. Böhler C, et al. Surgical treatment of shoulder infections: a comparison between arthroscopy and arthrotomy. J Shoulder Elbow Surg 2017; 26(11): 1915–1921.
  12. Peres LR, et al. Arthrotomy versus arthroscopy in the treatment of septic arthritis of the knee in adults: a randomized clinical trial. Knee Surg Sports Traumatol Arthrosc 2016; 24(10): 3155–3162.
  13. Puzzitiello RN, et al. Arthroscopic Treatment is a Safe and Effective Alternative to Open Treatment for Acute Septic Arthritis of the Native Knee: A Systematic Review. Arthroscopy 2023.
  14. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology (Oxford) 2001; 40(1): 24–30.
Labels
Dermatology & STDs Paediatric rheumatology Rheumatology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#